Table 1.
Predictors of disease-free survival: Univariate and multivariate analyses
Factor | Coefficient | Hazard ratio | 95% C.I. | P value |
---|---|---|---|---|
Univariate Cox model | ||||
No. of CD8+ TILs (continuous) | −0.06 | 0.94 | (0.90, 0.99) | 0.018 |
No. of CD8+ TILs (binary) | ||||
<8 | 1 | reference | ||
≥8 | −0.8 | 0.45 | (0.21, 0.96) | 0.034 |
Age | 0.01 | 1.01 | (0.98, 1.05) | 0.40 |
Disease stage | ||||
T1 or Ta | 1 | reference | ||
T2+ | 0.79 | 2.21 | (1.09, 4.49) | 0.025 |
Carcinoma in situ | ||||
No | 1 | reference | ||
Yes | −0.19 | 0.83 | (0.37, 1.87) | 0.650 |
Sex | ||||
Female | 1 | reference | ||
Male | −0.13 | 0.88 | (0.41, 1.85) | 0.730 |
Chemotherapy | ||||
No | 1 | reference | ||
Yes | 0.37 | 1.44 | (0.66, 3.14) | 0.360 |
MHC class I (HLA) expression | ||||
≤10 | 1 | reference | ||
>10+ | −0.64 | 0.53 | (0.25, 1.12) | 0.097 |
Multivariate Cox model | ||||
Disease stage T2+ (vs. T1/Ta) | 1.66 | 5.28 | (2.32, 13.62) | <0.001 |
No. of CD8+ TILs ≥8 (vs. <8) | −0.24 | 0.79 | (0.27, 2.33) | 0.670 |
Stage*CD8+ | −1.59 | 0.2 | (0.04, 0.90) | 0.040 |